Nazione: Australia
Lingua: inglese
Fonte: Department of Health (Therapeutic Goods Administration)
ceftazidime pentahydrate, Quantity: 1164.8 mg (Equivalent: ceftazidime, Qty 1000 mg)
Sandoz Pty Ltd
Injection, powder for
Excipient Ingredients: sodium carbonate
Intravenous, Intramuscular
5 vials, 10 vials, 1 vial
(S4) Prescription Only Medicine
Treatment of single and mixed infections caused by susceptible aerobic organisms with suspected or documented resistance to other antimicrobials, but not to ceftazidime; as an alternative to aminoglycosides in pseudomonal infection in patients in whom aminoglycoside toxicity is a cause for concern and other antipseudomonal antibiotics cannot be used. Indications include the folowing: Severe infections in general (e.g. septicaemia including neonatal sepsis, bacteraemia; in patients in intensive care units with specific problems, e.g. infected burns). Respiratory tract (e.g. pneumonia, bronchopneumonia, infected pleurisy, infected bronchiectasis and bronchitis). Severe ear, nose and throat infections (e.g. otitis media, mastoiditis). Urinary tract (e.g. acute and chronic pyelonephritis, pyelitis, cystitis - bacterial only; infections associated with bladder and renal stones). Skin and soft tissue (e.g. erysipelas abscesses, cellulitis, infected burns and wounds, mastitis). Gastrointestinal and abdominal (e.g. intra-abdominal abscesses, enterocolitis). Bone and joint (e.g. osteitis, osteomyelitis, septic arthritis, infected burstis).
Visual Identification: Clear glass vial with aluminium cap and plastic "flip-offs" containing a white to cream powder.; Container Type: Vial; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius
Licence status A
2003-06-05
CEFTAZIDIME SANDOZ ® 190129-cmi 1 CEFTAZIDIME SANDOZ ® _ceftazidime pentahydrate powder for injection _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Ceftazidime Sandoz. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you using Ceftazidime Sandoz against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT USING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT CEFTAZIDIME SANDOZ IS USED FOR The name of your medicine is Ceftazidime Sandoz. It contains the active ingredient ceftazidime pentahydrate. Ceftazidime Sandoz is an antibiotic used to treat infections in different parts of the body caused by bacteria. Ceftazidime Sandoz belongs to a group of antibiotics called cephalosporins. These antibiotics work by killing the bacteria that are causing your infection. Your doctor may have prescribed Ceftazidime Sandoz for another reason. Ask your doctor if you have any questions about why Ceftazidime Sandoz has been prescribed for you. Ceftazidime Sandoz is available only with a doctor's prescription. Ceftazidime Sandoz is not addictive. BEFORE YOU ARE GIVEN CEFTAZIDIME SANDOZ _WHEN YOU MUST NOT BE GIVEN _ _IT _ DO NOT USE CEFTAZIDIME SANDOZ IF: 1. YOU HAVE AN ALLERGY TO CEFTAZIDIME, ANY OF THE INGREDIENTS LISTED AT THE END OF THIS LEAFLET, OR ANY OTHER CEPHALOSPORINS Some of the symptoms of an allergic reaction may include wheezing, shortness of breath, swelling of the face, lips or tongue which may cause difficulty in swallowing or breathing, skin rash, itching or hives. 2. YOU HAVE HAD A SERIOUS ALLERGIC REACTION TO ANY PENICILLINS You may be more likely to have an allergic reaction to Ceftazidime Sandoz if you are allergic to penicillin medicines. DO NOT USE CEFTAZIDIME SANDOZ IF THE PACKAGING IS TORN OR SHOWS SIGNS OF TA Leggi il documento completo
190129-Ceftazidime Sandoz -pi Page 1 of 12 AUSTRALIAN PRODUCT INFORMATION CEFTAZIMIDE SANDOZ ® 1G POWDER FOR INJECTION (CEFTAZIMIDE PENTAHYDRATE) 1 NAME OF THE MEDICINE Ceftazidime (as pentahydrate) 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Ceftazidime Sandoz ® is a cephalosphorin antibiotic containing ceftazidime pentahydrate, a white to faintly yellow crystalline powder, soluble in acid and alkali solution; slightly soluble in water and in methanol; practically insoluble in acetone and in alcohol. On addition of water for injections, Ceftazidime Sandoz ® dissolves with effervescence to produce a solution for use by injection only. For laboratory tests associated with ceftazidime administration, ceftazidime pentahydrate should be used. For the full list of excipients, see Section 6.1 List of excipients. 3 PHARMACEUTICAL FORM Vial (powder for reconstitution): 1 g (for IM or IV use) 4 CLINICAL PARTICULARS 4.1 T HERAPEUTIC INDICATIONS Treatment of single and mixed infections caused by susceptible aerobic organisms with suspected or documented resistance to other antimicrobials, but not to ceftazidime; as an alternative to aminoglycosides in pseudomonal infection in patients in whom aminoglycoside toxicity is a cause for concern and other antipseudomonal antibiotics cannot be used. Ind ications include the following: • _SEVERE INFECTIONS IN GENERAL_ (e.g. _ _ septicaemia including neonatal sepsis, bacteraemia; in patients in intensive care units with specific problems, e.g. infected burns) _. _ • _RESPIRATORY TRACT_ (e.g. pneumonia, bronchopneumonia, infected pleurisy, infected bronchiectasis and bronchitis) _. _ • _SEVERE EAR, NOSE AND THROAT INFECTIONS_ (e.g. _ _ otitis media, mastoiditis). _ _ • _URINARY TRACT _ (e.g. _ _ acute and chronic pyelonephritis, pyelitis, cystitis, urethritis - bacterial only; infections associated with bladder and renal stones). • _SKIN AND SOFT TISSUE_ (e.g. erysipelas, abscesses, cellulitis, infected burns and wounds, mastitis). • _GASTROINTESTINAL AND ABDOMINAL_ (e.g Leggi il documento completo